GMP manufacturing pitfalls that delay biologics production can increase costs, disrupt clinical timelines, and compromise regulatory readiness if not addressed early.
Read more
The IR Sant Pau has received funding from the national call to advance the development of Fanconinib, the first specific inhibitor designed to block the FA/BRCA DNA repair pathway.
Read more
Investment in R&D reached €12.6 million, representing an increase of 50% (€4.2 million) compared to the €8.4 million invested in the previous financial year.
Read more
The AI revolution in Pharmaceutical R&D is transitioning from experimental curiosity to operational necessity. This transformation is supported by quantifiable operational improvements: AI-enabled dis...
Read more
Published in Science Advances, the study shows that the drug does not act on the protein in isolation, but instead takes advantage of the moment when they briefly group together into small complexes (...
Read more
El Hospital Gregorio Marañón ha coordinado un ensayo clínico que confirma la eficacia de la combinación de los fármacos lurbinectedina con pembrolizumab en pacientes con cáncer de pulmón microc...
Read more
The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.
Read more
Understanding the responsibilities involved in Drug Substance and Drug Product manufacturing is essential for making the right strategic decisions. Many biotech companies approaching clinical phases d...
Read more
The biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...
Read more
Manufacturing and Controls (CMC) framework ensures that every dose of an investigational product is safe, effective, and consistent in quality. As a candidate moves through the drug development stages...
Read more
Oryzon Genomics today announced that the Mexican Patent Office has issued a decision to grant for its patent application MX/a/2021/011610, entitled “Combinations of iadademstat for cancer therapy”...
Read more
Unlike current drugs, which mainly remove beta-amyloid plaques that accumulate in the brain, this new experimental drug reprogrammes the neuronal epigenome by correcting alterations in gene expression...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The study, which focused on people aged 80 and older with mild cogniti...
